email   Email Us: phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

ISSN: 2637-4722

Progressing Aspects in Pediatrics and Neonatology

Case Report(ISSN: 2637-4722)

Good Evolution of Stage IV Neuroblastoma in the Absence of Stem Cell Autograft

Volume 1 - Issue 4

Wala Ben Kridis1*, Ines Werda1, Rim Kallel2, Nabil Toumi1, Tahia Boudawara2, Afef Khanfir1 and Mounir Frikha1

  • Author Information Open or Close
    • 1Department of Oncology, Habib Bourguiba Hospital, Tunisia
    • 2Department of pathology, Habib Bourguiba Hospital, Tunisia

    *Corresponding author: Wala Ben Kridis, Department of oncology, Habib Bourguiba Hospital, Sfax Tunisia

Received: May 29, 2018;   Published: June 11, 2018

DOI: 10.32474/PAPN.2018.01.000119

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


Neuroblastoma is a relatively common pediatric pathology of the sympathetic nervous system. The particularity of neuroblastoma lies in its development from cells whose embryological maturation into adult sympathetic nerve cells or chromaffin cells is incomplete. In the literature, many cases of spontaneous regression of neuroblastoma have been reported, but the mechanisms for which they are responsible remain ambiguous. The specificity of our case is the benign evolution of an osteomedullary stage 4 neuroblastoma and its maturation into a ganglioneuroma 6 years after the end of chemotherapy. This transformation depends on various factors related to the tumor (such as the over expression or not of N-myc, the presence or absence of Treks and their receptors), the host (the intervention of the immune system) and to other external factors. Being able to induce this differentiation by not leaving it to chance would be a therapeutic challage and could categorically change the prognosis of neuroblastomas. This merits a lot of research and studies of various potential future treatments (such as treks inhibitors and retinoid).

Keywords: Neuroblastoma; Ganglioneuroma; Etiopathogeny

Abbrevations: NGF: Nerve Growth Factor; BDNF: Brain Derived Neutrophic Factor; VMA: Vanyl Mandelic Acid; NB: Neuroblastoma.

Abstract| Introduction| Case Report| Discussion| Conclusion| References|